Response to: 'Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service' by Elliott et al

Joseph Bush

doi:10.1136/bmjqs-2016-005465

Response to: 'Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service' by Elliott et al

Joseph Bush^*

^*Corresponding author for this work

Aston Pharmacy School

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

Abstract

Letter

Original language	English
Article number	e10
Journal	BMJ Quality and Safety
Volume	26
Issue number	4
DOIs	https://doi.org/10.1136/bmjqs-2016-005465
Publication status	Published - 13 Apr 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

accreditation
adverse events epidemiology and detection
ambulatory care

Access to Document

10.1136/bmjqs-2016-005465

Fingerprint

Dive into the research topics of 'Response to: 'Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service' by Elliott et al'. Together they form a unique fingerprint.

Cite this

@article{a0057999176e402fba6b0e5c1f03ba21,

title = "Response to: 'Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service' by Elliott et al",

abstract = "Letter",

keywords = "accreditation, adverse events epidemiology and detection, ambulatory care",

author = "Joseph Bush",

year = "2017",

month = apr,

day = "13",

doi = "10.1136/bmjqs-2016-005465",

language = "English",

volume = "26",

journal = "BMJ Quality and Safety",

issn = "2044-5415",

publisher = "BMJ Publishing Group",

number = "4",

}

Response to: 'Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service' by Elliott et al. / Bush, Joseph.
In: BMJ Quality and Safety, Vol. 26, No. 4, e10, 13.04.2017.

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

TY - JOUR

T1 - Response to: 'Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service' by Elliott et al

AU - Bush, Joseph

PY - 2017/4/13

Y1 - 2017/4/13

N2 - Letter

AB - Letter

KW - accreditation

KW - adverse events epidemiology and detection

KW - ambulatory care

UR - https://www.scopus.com/pages/publications/85016984569

U2 - 10.1136/bmjqs-2016-005465

DO - 10.1136/bmjqs-2016-005465

M3 - Letter, comment/opinion or interview

AN - SCOPUS:85016984569

SN - 2044-5415

VL - 26

JO - BMJ Quality and Safety

JF - BMJ Quality and Safety

IS - 4

M1 - e10

ER -

Response to: 'Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: A pragmatic randomised controlled trial of the New Medicine Service' by Elliott et al

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this